First Time Loading...

BridgeBio Pharma Inc
NASDAQ:BBIO

Watchlist Manager
BridgeBio Pharma Inc Logo
BridgeBio Pharma Inc
NASDAQ:BBIO
Watchlist
Price: 29.97 USD 3.52% Market Closed
Updated: May 16, 2024

BridgeBio Pharma Inc
Income to Minority Interest

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

BridgeBio Pharma Inc
Income to Minority Interest Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Income to Minority Interest Analysis
Latest Figures & CAGR of Competitors

Company Income to Minority Interest CAGR 3Y CAGR 5Y CAGR 10Y
BridgeBio Pharma Inc
NASDAQ:BBIO
Income to Minority Interest
$8.4m
CAGR 3-Years
-46%
CAGR 5-Years
-30%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Income to Minority Interest
-$10m
CAGR 3-Years
-19%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Income to Minority Interest
$26m
CAGR 3-Years
-2%
CAGR 5-Years
54%
CAGR 10-Years
4%
Amgen Inc
NASDAQ:AMGN
Income to Minority Interest
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Income to Minority Interest
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Income to Minority Interest
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is BridgeBio Pharma Inc's Income to Minority Interest?
Income to Minority Interest
8.4m USD

Based on the financial report for Mar 31, 2024, BridgeBio Pharma Inc's Income to Minority Interest amounts to 8.4m USD.

What is BridgeBio Pharma Inc's Income to Minority Interest growth rate?
Income to Minority Interest CAGR 5Y
-30%

Over the last year, the Income to Minority Interest growth was 658%. The average annual Income to Minority Interest growth rates for BridgeBio Pharma Inc have been -46% over the past three years , -30% over the past five years .